|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/113 | |
| C12N 15/10 | |||
| A61K 31/712 |
| (11) | Number of the document | 3507366 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17771348.4 |
| Date of filing the European patent application | 2017-08-31 | |
| (97) | Date of publication of the European application | 2019-07-10 |
| (45) | Date of publication and mention of the grant of the patent | 2020-10-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2017/071912 |
| Date | 2017-08-31 |
| (87) | Number | WO 2018/041973 |
| Date | 2018-03-08 |
| (30) | Number | Date | Country code |
| 201614858 | 2016-09-01 | GB | |
| 201616374 | 2016-09-27 | GB | |
| 201621467 | 2016-12-16 | GB | |
| 201703034 | 2017-02-24 | GB | |
| 201707508 | 2017-05-10 | GB |
| (72) |
TURUNEN, Janne Juha, NL
AALTO, Antti, NL
KLEIN, Bart, NL
VAN SINT FIET, Lenka, NL
BOUDET, Julien Auguste Germain, NL
|
| (73) |
ProQR Therapeutics II B.V.,
Zernikedreef 9, 2333 CK Leiden,
NL
|
| (54) | CHEMICALLY MODIFIED SINGLE-STRANDED RNA-EDITING OLIGONUCLEOTIDES |
| CHEMICALLY MODIFIED SINGLE-STRANDED RNA-EDITING OLIGONUCLEOTIDES |